| 11/16/2026 4:04 PM | ENDRA Life Sciences (1681682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/16/2026 4:06 PM | ENDRA Life Sciences (1681682) Subject | Form 425 | |
| 11/10/2026 6:54 AM | ENDRA Life Sciences (1681682) Subject Salt Rock Capital Partners LLP (2163773) Filed by | Form SCHEDULE 13G | |
| 10/26/2026 3:16 PM | ASP Isotopes Inc. (1921865) Filed by ENDRA Life Sciences (1681682) Subject | Form 425 | |
| 10/08/2026 3:15 PM | ASP Isotopes Inc. (1921865) Filed by ENDRA Life Sciences (1681682) Subject | Form SCHEDULE 13D | |
| 10/08/2026 3:15 PM | ASP Isotopes Inc. (1921865) Reporting ENDRA Life Sciences (1681682) Issuer LHE LNG Holdings LLC (2157843) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/01/2026 4:18 PM | ENDRA Life Sciences (1681682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/01/2026 4:21 PM | ENDRA Life Sciences (1681682) Subject | Form 425 | |
| 09/25/2026 4:09 PM | ENDRA Life Sciences (1681682) Subject | Form 425 | |
| 09/14/2026 4:15 PM | ENDRA Life Sciences (1681682) Subject | Form 425 | |
| 09/09/2026 5:30 AM | ASP Isotopes Inc. (1921865) Filed by ENDRA Life Sciences (1681682) Subject | Form 425 | |
Get the Latest News and Ratings for NDRA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ENDRA Life Sciences and its competitors with MarketBeat's FREE daily newsletter.
|
| 09/09/2026 5:33 AM | ASP Isotopes Inc. (1921865) Filed by ENDRA Life Sciences (1681682) Subject | Form 425 | |
| 08/20/2026 7:22 PM | ASP Isotopes Inc. (1921865) Filed by ENDRA Life Sciences (1681682) Subject | Form 425 | |
| 08/20/2026 7:10 AM | ASP Isotopes Inc. (1921865) Filed by ENDRA Life Sciences (1681682) Subject | Form 425 | |
| 08/17/2026 3:05 PM | ENDRA Life Sciences (1681682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/17/2026 3:07 PM | ENDRA Life Sciences (1681682) Subject | Form 425 | |
| 08/06/2026 7:15 AM | ASP Isotopes Inc. (1921865) Filed by ENDRA Life Sciences (1681682) Subject | Form 425 | |
| 08/05/2026 4:07 PM | ASP Isotopes Inc. (1921865) Filed by ENDRA Life Sciences (1681682) Subject | Form 425 | |
| 08/04/2026 4:25 PM | ASP Isotopes Inc. (1921865) Filed by ENDRA Life Sciences (1681682) Subject | Form 425 | |
| 07/22/2026 7:35 AM | ASP Isotopes Inc. (1921865) Filed by ENDRA Life Sciences (1681682) Subject | Form 425 | |
| 07/22/2026 5:01 AM | ASP Isotopes Inc. (1921865) Filed by ENDRA Life Sciences (1681682) Subject | Form 425 | |
| 07/17/2026 7:20 AM | ENDRA Life Sciences (1681682) Subject | Form 425 | |
| 07/17/2026 7:20 AM | ASP Isotopes Inc. (1921865) Filed by ENDRA Life Sciences (1681682) Subject | Form 425 | |
| 07/09/2026 5:08 AM | ENDRA Life Sciences (1681682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/29/2026 8:29 PM | DIGIANDOMENICO ANTHONY (1083544) Filed by ENDRA Life Sciences (1681682) Subject | Form SCHEDULE 13D/A | |
| 06/26/2026 5:10 AM | ENDRA Life Sciences (1681682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/26/2026 5:16 AM | ENDRA Life Sciences (1681682) Subject | Form 425 | |
| 06/25/2026 5:24 PM | DIGIANDOMENICO ANTHONY (1083544) Reporting ENDRA Life Sciences (1681682) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/25/2026 4:25 PM | ASP Isotopes Inc. (1921865) Filed by ENDRA Life Sciences (1681682) Subject | Form 425 | |
| 06/25/2026 8:38 AM | ENDRA Life Sciences (1681682) Subject | Form 425 | |
| 06/25/2026 8:37 AM | ENDRA Life Sciences (1681682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/28/2026 5:07 AM | ENDRA Life Sciences (1681682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/26/2026 3:59 PM | ENDRA Life Sciences (1681682) Filer | Form RW | |
| 04/21/2026 7:00 AM | ENDRA Life Sciences (1681682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/31/2026 4:10 PM | ENDRA Life Sciences (1681682) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/25/2026 8:21 AM | ENDRA Life Sciences (1681682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/04/2026 8:48 PM | ENDRA Life Sciences (1681682) Issuer Jacroux Richard (2033818) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 8:48 PM | ENDRA Life Sciences (1681682) Issuer Tokman Alexander Y (1334483) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/23/2026 6:42 PM | ENDRA Life Sciences (1681682) Issuer Tokman Alexander Y (1334483) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/23/2026 6:43 PM | Basenese Lou (1809482) Reporting ENDRA Life Sciences (1681682) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/23/2026 6:43 PM | ENDRA Life Sciences (1681682) Issuer Jacroux Richard (2033818) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Why I'm selling my Snapback Indicator for just $7 (Ad) For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500.
The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long.
No strings attached, and Wood says there is an unusual reason behind the steep discount. Get lifetime access to the Snapback Indicator for a one-time $7 payment today. |
| 01/23/2026 6:43 PM | ENDRA Life Sciences (1681682) Issuer Harsh Michael (1706155) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/23/2026 6:44 PM | DIGIANDOMENICO ANTHONY (1083544) Reporting ENDRA Life Sciences (1681682) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/12/2025 7:31 PM | ENDRA Life Sciences (1681682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/28/2025 3:23 PM | ENDRA Life Sciences (1681682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/26/2025 3:30 PM | DIGIANDOMENICO ANTHONY (1083544) Filed by ENDRA Life Sciences (1681682) Subject | Form SCHEDULE 13D | |
| 11/26/2025 7:30 AM | ENDRA Life Sciences (1681682) Filer | Form 424B4 | |